Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty Contrast-Induced Nephropathy] Trial
Patti G;
2011-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Am J Cardiol 2011-ARMYDA-CIN.pdf
file disponibile solo agli amministratori
Dimensione
811.08 kB
Formato
Adobe PDF
|
811.08 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
